Literature DB >> 7473709

Studies on the lumazine synthase/riboflavin synthase complex of Bacillus subtilis: crystal structure analysis of reconstituted, icosahedral beta-subunit capsids with bound substrate analogue inhibitor at 2.4 A resolution.

K Ritsert1, R Huber, D Turk, R Ladenstein, K Schmidt-Bäse, A Bacher.   

Abstract

The lumazine synthase/riboflavin synthase of Bacillus subtilis is a bifunctional enzyme complex catalysing the formation of riboflavin from 5-amino-6-(D-ribitylamino)-2,4(1H,3H)-pyrimidinedione and L-3,4-dihydroxy-2-butanone-4-phosphate via 6,7-dimethyl-8-ribityllumazine. The complex is composed of 3 alpha (riboflavin synthase) subunits and 60 beta (lumazine synthase) subunits and has a relative mass of 1 MDa. The 60 beta subunits are arranged in an icosahedral capsid enclosing the alpha trimer in the central core. The protein was crystallised, and an X-ray structure of the icosahedral capsid was obtained at 3.3 A resolution with a crystallographic R-factor of 0.33. Hollow, icosahedral capsids consisting of 60 beta subunits can be obtained by inhibitor-driven renaturation of isolated beta subunits. They catalyse the formation of 6,7-dimethyl-8-ribityllumazine at the same rate as the native alpha 3 beta 60 complex and can be crystallised in two different hexagonal and one monoclinic form. Crystallographic intensity data of the monoclinic crystals to a resolution of 2.4 A were obtained using synchrotron radiation and an image plate detector system. The orientation of the icosahedral molecules in the monoclinic cell was deduced by real space vector search procedures from a 3.5 A Patterson map. Phases were calculated from the model of the alpha 3 beta 60 protein and were extended by cyclic averaging exploring the 30-fold redundancy of the electron density. The 2.4 A map allowed us to refine the existing atomic model of lumazine synthase. The refined model includes 154 amino acid residues, one inhibitor molecule, 58 water molecules and one phosphate ion. Applying non-crystallographic-symmetry restraints the crystallographic R-factor is 16.7% for 100,092 reflections between 10 and 2.4 A. The chain folding of the beta subunits is closely similar to the native alpha 3 beta 60 enzyme. The lumazine synthase bears resemblance to the sugar binding proteins. The significantly higher resolution compared to the alpha 3 beta 60 structure determination allows a detailed description of the substrate analogue binding site. The environment of the 5-nitro-6-(D-ribitylamino)-2,4(1H,3H)-pyrimidinedione inhibitor is particularly rigid, and the chain segments involved in forming the active site are highly conserved for lumazine synthases of different species. A residual density feature in the final map is interpreted as a bound phosphate which mimics the binding of the second substrate. We discuss the reaction mechanism on this structural basis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473709     DOI: 10.1006/jmbi.1995.0542

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  19 in total

1.  A method for soluble overexpression of the alpha7 nicotinic acetylcholine receptor extracellular domain.

Authors:  M Fischer; P J Corringer; K Schott; A Bacher; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Predicted highly expressed genes of diverse prokaryotic genomes.

Authors:  S Karlin; J Mrázek
Journal:  J Bacteriol       Date:  2000-09       Impact factor: 3.490

3.  Crystal structure analysis of a pentameric fungal and an icosahedral plant lumazine synthase reveals the structural basis for differences in assembly.

Authors:  K Persson; G Schneider; D B Jordan; P V Viitanen; T Sandalova
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

4.  Improvement of the quality of lumazine synthase crystals by protein engineering.

Authors:  Lidia Rodríguez-Fernández; F Javier López-Jaramillo; Adelbert Bacher; Markus Fischer; Sevil Weinkauf
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-06-11

5.  Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of tetrahydrodipicolinate-N-succinyltransferase (Rv1201c) from Mycobacterium tuberculosis.

Authors:  Linda Schuldt; Simone Weyand; Georgia Kefala; Manfred S Weiss
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-08-29

6.  Virtual screening, selection and development of a benzindolone structural scaffold for inhibition of lumazine synthase.

Authors:  Arindam Talukdar; Ekaterina Morgunova; Jianxin Duan; Winfried Meining; Nicolas Foloppe; Lennart Nilsson; Adelbert Bacher; Boris Illarionov; Markus Fischer; Rudolf Ladenstein; Mark Cushman
Journal:  Bioorg Med Chem       Date:  2010-04-08       Impact factor: 3.641

7.  Crystallographic and kinetic study of riboflavin synthase from Brucella abortus, a chemotherapeutic target with an enhanced intrinsic flexibility.

Authors:  María I Serer; Hernán R Bonomi; Beatriz G Guimarães; Rolando C Rossi; Fernando A Goldbaum; Sebastián Klinke
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-04-30

8.  Design, synthesis, and biochemical evaluation of 1,5,6,7-tetrahydro-6,7-dioxo-9-D-ribitylaminolumazines bearing alkyl phosphate substituents as inhibitors of lumazine synthase and riboflavin synthase.

Authors:  Mark Cushman; Guangyi Jin; Thota Sambaiah; Boris Illarionov; Markus Fischer; Rudolf Ladenstein; Adelbert Bacher
Journal:  J Org Chem       Date:  2005-09-30       Impact factor: 4.354

9.  The C-terminal peptide of Aquifex aeolicus riboflavin synthase directs encapsulation of native and foreign guests by a cage-forming lumazine synthase.

Authors:  Yusuke Azuma; Reinhard Zschoche; Donald Hilvert
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

10.  An in vitro deletion in ribE encoding lumazine synthase contributes to nitrofurantoin resistance in Escherichia coli.

Authors:  Jascha Vervoort; Basil Britto Xavier; Andrew Stewardson; Samuel Coenen; Maciek Godycki-Cwirko; Niels Adriaenssens; Anna Kowalczyk; Christine Lammens; Stephan Harbarth; Herman Goossens; Surbhi Malhotra-Kumar
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.